Weekly Intelligence · 5 articles

Vet Industry Intel: Aug 30 – Sep 5, 2026

High-signal veterinary industry stories triangulated from multiple sources, scored for relevance, and grouped by event type.

Acquisitions & M&A (2) Regulatory & Policy (2) Products & Technology (1)

Acquisitions & M&A

Aug 30, 2026 [9/10] businesswire_vet

BiomEdit Acquires Folium Science To Expand Programmable Veterinary Biologics - Pulse 2.0

BiomEdit has acquired Folium Science to broaden its portfolio of programmable biologics for veterinary applications.

BiomEdit · Folium Science

Aug 30, 2026 [9/10] gnews_zoetis

Phibro Animal Health: Zoetis Integrated And Better Cash Flow Ahead (NASDAQ:PAHC) - Seeking Alpha

Zoetis has integrated Phibro Animal Health, reporting improved cash flow as a result of the acquisition.

Phibro Animal Health · Zoetis | NY

Regulatory & Policy

Sep 1, 2026 [9/10] vpn

A DMOAD works differently.

The FDA has approved a new disease-modifying osteoarthritis drug for dogs, offering a new treatment option for canine OA patients.

FDA

Aug 31, 2026 [8/10] dvm360

Three recent recalls affect IV fluids, dog food, and feline milk replacers - DVM360

Three recalls were announced affecting IV fluids, dog food, and feline milk replacers.

DVM360

Products & Technology

Aug 31, 2026 [9/10] fda_cvm

Cronus Pharma Launches FDA-Approved Robenacoxib Injection for Veterinary Use - Machine Maker

Cronus Pharma has launched an FDA-approved robenacoxib injection for veterinary use.

Cronus Pharma · FDA · Machine Maker

Most-mentioned this week

Zoetis (1)